The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 14, Issue 2, 2009, Pages 116-124

  Keswani, Amit N ^a   Peyton, Kelly J ^b   Durante, William ^b   Schafer, Andrew I ^c   Tulis, David A ^d,e  

^a University of Texas Medical Branch School of Medicine   (United States)

^b University of Missouri   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Apoptosis; Carotid artery balloon injury; Proliferation; YC 1; Zaprinast

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; ACEPROMAZINE; BUPRENORPHINE; CELL ANTIGEN; CYCLIC GMP; KETAMINE; XYLAZINE; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAROTID ARTERY INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; INTIMA; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CAROTID ARTERY INJURIES; CELL PROLIFERATION; CYCLIC GMP; DISEASE MODELS, ANIMAL; ENZYME ACTIVATORS; GUANYLATE CYCLASE; INDAZOLES; MALE; PHOSPHODIESTERASE INHIBITORS; PURINONES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 65949113391     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248409333266     Document Type: Article

References (36)

1. Tulis DA, Durante W., Liu XM, Evans AJ, Peyton KJ, Schafer AI Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 2001 ; 104: 2710-2715. (Pubitemid 33108139)
2. Tulis DA, Durante W., Peyton KJ, Evans AJ, Schafer AI Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis. 2001 ; 155: 113-122. (Pubitemid 32167130)
3. Tulis DA, Keswani AN, Peyton KJ, Wang H., Schafer AI, Durante W. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cell Mol Biol. 2005 ; 51: 441-446. (Pubitemid 41596300)
4. Ko FN, Wu CC, Kuo SC, Lee FY, Teng CM YC-1, a novel activator of platelet guanylate cyclase. Blood. 1994 ; 84: 4226-4233. (Pubitemid 24371926)
5. Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol. 1995 ; 116: 1973-1978.
6. Tulis DA, Durante W., Peyton KJ, Chapman GB, Evans AJ, Schafer AI YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. Biochem Biophys Res Commun. 2000 ; 279: 646-652. (Pubitemid 32016768)
7. Tulis DA, Bohl Masters KS, Lipke EA, et al. YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function. Biochem Biophys Res Commun. 2002 ; 291: 1014-1021. (Pubitemid 34694377)
8. Wu CH, Chang WC, Chang GY, Kuo SC, Teng CM The inhibitory mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: an in vitro and in vivo study. J Pharmacol Sci. 2004 ; 94: 252-260. (Pubitemid 38470734)
9. Tulis DA Salutary properties of YC-1 in the cardiovascular and hematological systems. Curr Med Chem Cardiovasc Hematol Agents. 2004 ; 2: 343-359. (Pubitemid 39200179)
10. Liu YC, Pan SL, Peng CY, et al. YC-1 [3-(50-hydroxymethyl-20-furyl)-1- benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9. J Pharmacol Exp Ther. 2006 ; 316: 35-41. (Pubitemid 41832578)
11. Tulis DA Novel therapies for cyclic GMP control of vascular smooth muscle growth. Am J Ther. 2008 ; 15: 551-564.
12. Stowe F., Novalija E. Phosphodiesterase type 5 inhibition enhances vasorelaxation caused by nitroprusside in guinea pig intact heart and isolated aorta. J Cardiovasc Pharmacol. 2000 ; 36: 162-168. (Pubitemid 30659835)
13. Kulkarni SK, Patil CS Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Methods Find Exp Clin Pharmacol. 2004 ; 26: 789-799. (Pubitemid 40193976)
14. Tsai BM, Wang M., Pitcher JM, Kher A., Crisostomo P., Meldrum DR Zaprinast attenuates hypoxic pulmonary artery injury and causes less aortic relaxation than milrinone. Shock. 2005 ; 24: 417-420. (Pubitemid 41567352)
15. Schutte H., Witzenrath M., Mayer K., et al. The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs. Am J Physiol Lung Cell Mol Physiol. 2000 ; 279: L496 - L502.
16. Vemulapalli S., Chiu PJ, Kurowski S., Brown A., Hartman DB, Leach MW In vivo inhibition of platelet adhesion by a cGMP-mediated mechanism in balloon catheter injured rat carotid artery. Pharmacology. 1996 ; 52: 235-242. (Pubitemid 26095762)
17. Indolfi C., Avvedimento EV, Di Lorenzo E., et al. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med. 1997 ; 3: 775-779. (Pubitemid 27298723)
18. Inoue Y., Toga K., Sudo T., et al. Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model. Br J Pharmacol. 2000 ; 130: 231-241. (Pubitemid 30261032)
19. Kim MJ, Park KG, Lee KM, et al. Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F. Hypertension. 2005 ; 45: 552-556. (Pubitemid 40411258)
20. Tulis DA Rat carotid artery balloon injury model. Methods Mol Med. 2007 ; 139: 1-30.
21. Tulis DA Histological and morphometric analyses for rat carotid artery balloon injury studies. Methods Mol Med. 2007 ; 139: 31-66.
22. Abbott RE, Schachter D. Regional differentiation in rat aorta, L-arginine metabolism and cGMP content in vitro. Am J Physiol. 1994 ; 266: H2287 - H2295. (Pubitemid 2111556)
23. Chiang WC, Teng CM, Lin SL, Chen YM, Tsai TJ, Hsieh BS YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor. Eur J Pharmacol. 2005 ; 517: 1-10. (Pubitemid 40910246)
24. Redondo J., Bishop JE, Wilkins MR Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts. Br J Pharmacol. 1998 ; 124: 1455-1462. (Pubitemid 28360569)
25. Friebe A., Mullershausen F., Smolenski A., Walter U., Schultz G., Koesling D. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol Pharmacol. 1998 ; 54: 962-967. (Pubitemid 29002038)
26. Galle J., Zabel U., Hubner U., et al. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br J Pharmacol. 1999 ; 127: 195-203. (Pubitemid 29213249)
27. Hwang TL, Zhuo SK, Pan YL YC-1 attenuates homotypic neutrophil aggregation through inhibition of phosphodiesterase activity. Eur J Pharmacol. 2007 ; 579: 395-402.
28. Hamad AM, Knox AJ Mechanisms mediating the antiproliferative effects of nitric oxide in cultured human airway smooth muscle cells. FEBS Lett. 2001 ; 506: 91-96. (Pubitemid 32925206)
29. Cook ALM, Haynes JM Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells. Cell Signal. 2004 ; 16: 253-261. (Pubitemid 37441272)
30. Zhu B., Strada S., Stevens T. Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2005 ; 289: L196 - L206. (Pubitemid 41008901)
31. Pozner RG, Negrotto S., D'Atri LP, et al. Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis. Br J Pharmacol. 2005 ; 145: 283-292. (Pubitemid 40896073)
32. Wu CF, Bishopric NH, Pratt RE Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem. 1997 ; 272: 14860-14866. (Pubitemid 27251756)
33. Sarfati M., Mateo V., Baudet S., et al. Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells. Blood. 2003 ; 101: 265-269. (Pubitemid 36025917)
34. Brunetti M., Mascetra N., Manarini S., et al. Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosis. Biochem Biophys Res Commun. 2002 ; 297: 498-501.
35. Ferrero R., Torres M. Prolonged exposure to YC-1 induces apoptosis in adrenomedullary endothelial and chromaffin cells through a cGMP-independent mechanism. Neuropharm. 2001 ; 41: 895-906. (Pubitemid 33001424)
36. Lukowski R., Weinmeister P., Bernhard D., et al. Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis. Arterioscler Thromb Vasc Biol. 2008 ; 28: 1244-1250.